Sickle Cell Disease (SCD) Decision Aid

NACompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

May 15, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Sickle Cell Disease
Interventions
OTHER

Qualitative Interviews Decisional Needs Assessment

Subjects will participate in an open-ended interview regarding type of sickle cell disease, complications, current treatment, and experiences with decision making and sickle cell treatment. Participants will be asked to describe what is important when making health care decisions. Treatment options (hydroxyurea, chronic or monthly blood transfusions, and bone marrow transplantation) will be discussed as well as how a web-based decision aid tool should be developed. The interview will be audio recorded and will take 45 to 60 minutes to complete.

OTHER

Sickle Cell Decision Aid

Participants will be asked to navigate the Sickle Cell Decision Aid site that provides information about risks and benefits of therapies. As the participant navigates the site, the interviewer will ask the participants to describe thoughts about the site, including but not limited to ease of navigation, content and construction. Testing may be performed in-person or via telephone. Interviews will be audio recorded and take up to 60 to 90 minutes to complete.

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Emory University

OTHER

NCT03224429 - Sickle Cell Disease (SCD) Decision Aid | Biotech Hunter | Biotech Hunter